Gastrointestinal symptoms: alteration in bowel motility, such as mild diarrhea or constipation, and loss of bladder or bowel control
CJC-1295 with DAC is often discussed at 12 mg once or twice weekly, while CJC-1295 without DAC is often discussed at 100200 mcg per dose, once or twice daily
however, side effects might occur, particularly during the first few weeks of treatment or following a dosage increase
Cells were treated with indicated concentrations of tunicamycin (TM) for 8 h
Accurate documentation and adherence to frequency limits are necessary to avoid denials
In addition, activated immune cells significantly generate ROS, increasing oxidative stress ( FIGURE 4 Cyprinus carpio haematopterus